Swedbank Ab Gilead Sciences, Inc. Transaction History

Swedbank Ab

$77.1 Billion
Q3 2024

A detailed history of Swedbank Ab transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Swedbank Ab holds 2,047,609 shares of GILD stock, worth $188 Million. This represents 0.22% of its overall portfolio holdings.

Number of Shares

2,047,609

Previous 1,857,987 10.21%

Holding current value

$188 Million

Previous $127 Million 34.64%

% of portfolio

0.22%

Previous 0.17%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 15, 2024	BUY	$66.59 - $83.99 $12.6 Million - $15.9 Million	189,622 Added 10.21%	2,047,609 $172 Million
Q2 2024 Jul 18, 2024	BUY	$63.15 - $72.88 $117 Million - $135 Million	1,857,987 New	1,857,987 $127 Million
Q1 2024 May 14, 2024	BUY	$71.58 - $87.29 $131 Million - $160 Million	1,836,028 New	1,836,028 $134 Million
Q4 2023 Dec 09, 2024	SELL	$73.27 - $83.09 $999,842 - $1.13 Million	-13,646 Reduced 0.82%	1,660,410 $135 Million
Q3 2023 Dec 09, 2024	SELL	$73.94 - $80.67 $3.71 Million - $4.05 Million	-50,198 Reduced 2.91%	1,674,056 $125 Million
Q2 2023 Dec 09, 2024	BUY	$76.01 - $86.7 $255,241 - $291,138	3,358 Added 0.2%	1,724,254 $133 Million
Q1 2023 Dec 09, 2024	SELL	$77.31 - $88.08 $7.27 Million - $8.28 Million	-94,033 Reduced 5.18%	1,720,896 $143 Million
Q4 2022 Dec 09, 2024	BUY	$62.32 - $89.47 $3.09 Million - $4.43 Million	49,511 Added 2.8%	1,814,929 $156 Million
Q3 2022 Dec 09, 2024	BUY	$59.54 - $68.01 $449,943 - $513,951	7,557 Added 0.43%	1,765,418 $109 Million
Q2 2022 Dec 09, 2024	SELL	$57.72 - $65.01 $2.84 Million - $3.2 Million	-49,185 Reduced 2.72%	1,757,861 $109 Million
Q1 2022 Dec 09, 2024	BUY	$57.92 - $72.58 $167,736 - $210,191	2,896 Added 0.16%	1,807,046 $107 Million
Q4 2021 Dec 09, 2024	SELL	$64.88 - $73.64 $3.06 Million - $3.48 Million	-47,210 Reduced 2.55%	1,804,150 $131 Million
Q3 2021 Dec 09, 2024	SELL	$67.69 - $73.03 $8.62 Million - $9.3 Million	-127,402 Reduced 6.44%	1,851,360 $129 Million
Q2 2021 Dec 09, 2024	SELL	$63.47 - $69.35 $29.1 Million - $31.8 Million	-458,115 Reduced 18.8%	1,978,762 $136 Million
Q1 2021 Dec 09, 2024	BUY	$60.0 - $68.46 $146 Million - $167 Million	2,436,877 New	2,436,877 $157 Million

Others Institutions Holding GILD

# of Institutions

1,941

Shares Held

989M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $115B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Swedbank Ab, based on Form 13F filings with the SEC.

News

Stay updated on Swedbank Ab with notifications on news.

Account